Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation THT 2026

Serial Echocardiography After Greater Splanchnic Nerve Ablation In Hfpef Demonstrates Reductions In LV Filling Pressures In Clinical Responders But Not In Nonresponders: 12 Month Follow Up In The REBALANCE-HF Trial

Presenter: Sheldon E. Litwin

March 04, 2026

Presentation THT 2026

A novel echocardiography modality for the detection of ATTR amyloid cardiomyopathy: real time myocardial 3D shear wave elastography

Presenter: mathieu pernot

March 03, 2026

Presentation THT 2026

Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics - Late Breaking Echocardiography Results from the CardiAMP HF trial

Presenter: Amish Raval

March 02, 2026

Presentation THT 2025

Use of AI-Based Automated Detection of Clinically Significant VHD From Echocardiography

Presenter: Akhil Narang

February 12, 2025

Presentation THT 2024

Imaging in HFpEF Trials: Going Beyond Echocardiography

Presenter: Robert O. Bonow

March 05, 2024

Presentation THT 2023

Prognostic Value of Strain Echocardiography in Patients with Sarcoidosis

Presenter: Gregory Despotidis

March 21, 2023

Presentation THT 2023

Association of Strain Echocardiography Measurements with Cardiovascular Outcomes in Patients with Sarcoidosis

Presenter: Gregory Despotidis

March 21, 2023

Advertisement

Serial Echocardiography After Greater Splanchnic Nerve Ablation In Hfpef Demonstrates Reductions In LV Filling Pressures In Clinical Responders But Not In Nonresponders: 12 Month Follow Up In The REBALANCE-HF Trial

A novel echocardiography modality for the detection of ATTR amyloid cardiomyopathy: real time myocardial 3D shear wave elastography

Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics - Late Breaking Echocardiography Results from the CardiAMP HF trial

Use of AI-Based Automated Detection of Clinically Significant VHD From Echocardiography

Imaging in HFpEF Trials: Going Beyond Echocardiography

Prognostic Value of Strain Echocardiography in Patients with Sarcoidosis

Association of Strain Echocardiography Measurements with Cardiovascular Outcomes in Patients with Sarcoidosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content